Clinical use of unfractionated heparin therapy in children: time for change?NEWALL, Fiona; IGNJATOVIC, Vera; JOHNSTON, Linda et al.British journal of haematology. 2010, Vol 150, Num 6, pp 674-678, issn 0007-1048, 5 p.Article

Age is a determinant factor for measures of concentration and effect in children requiring unfractionated heparinNEWALL, Fiona; IGNJATOVIC, Vera; JOHNSTON, Linda et al.Thrombosis and haemostasis. 2010, Vol 103, Num 5, pp 1085-1090, issn 0340-6245, 6 p.Article

Monitoring unfractionated heparin with the aPTT : Time for a fresh look : Laboratory methods in the haemostatic laboratoryEIKELBOOM, John W; HIRSH, Jack.Thrombosis and haemostasis. 2006, Vol 96, Num 5, pp 547-552, issn 0340-6245, 6 p.Article

Lack of correlation between heparin dose and standard clinical monitoring tests in treatment with unfractionated heparin in critically III childrenKUHLE, Stefan; EULMESEKIAN, Pablo; KAVANAGH, Brian et al.Haematologica (Roma). 2007, Vol 92, Num 4, pp 554-557, issn 0390-6078, 4 p.Article

Standardisation of Unfractionated and Low-Molecular-Weight HeparinGRAY, Elaine.Handbook of experimental pharmacology. 2012, Vol 207, pp 65-76, issn 0171-2004, 12 p.Article

Inaccuracy of a Spiked Curve for Monitoring Unfractionated Heparin TherapyGAUSMAN, Jana N; MARLAR, Richard A.American journal of clinical pathology. 2011, Vol 135, Num 6, pp 870-876, issn 0002-9173, 7 p.Article

Composition of OSCS-contaminated heparin occurring in 2008 in batches on the German marketBEYER, Tanja; MATZ, Magnus; BRINZ, Daniela et al.European journal of pharmaceutical sciences. 2010, Vol 40, Num 4, pp 297-304, issn 0928-0987, 8 p.Article

Bridging therapy and oral anticoagulation: current and future prospectsSPYROPOULOS, Alex C.Current opinion in hematology. 2010, Vol 17, Num 5, pp 444-449, issn 1065-6251, 6 p.Article

Surgical bleeding after pre-operative unfractionated heparin and low molecular weight heparin for coronary bypass surgeryRENDA, Giulia; DI PILLO, Raffaele; D'ALLEVA, Alberto et al.Haematologica (Roma). 2007, Vol 92, Num 3, pp 366-373, issn 0390-6078, 8 p.Article

Comparison of the antiangiogenic effects of heparin sodium, enoxaparin sodium, and tinzaparin sodium by using chorioallantoic membrane assayKATRANCIOGLU, Nurkay; KARAHAN, Oguz; TURHAN KILIC, Ahmet et al.Blood coagulation & fibrinolysis. 2012, Vol 23, Num 3, pp 218-221, issn 0957-5235, 4 p.Article

Identifying Optimal Initial Infusion Rates for Unfractionated Heparin in Morbidly Obese PatientsRINEY, Jennifer N; HOLLANDS, James M; SMITH, Jennifer R et al.The Annals of pharmacotherapy. 2010, Vol 44, Num 7-8, pp 1141-1151, issn 1060-0280, 11 p.Article

Novel interactions between UFH and TFPI in childrenNEWALL, Fiona; JOHNSTON, Linda; SUMMERHAYES, Robyn et al.British journal of haematology. 2010, Vol 151, Num 4, pp 376-380, issn 0007-1048, 5 p.Article

A clinically significant incidence of bleeding in critically ill children receiving therapeutic doses of unfractionated heparin : a prospective cohort studyKUHLE, Stefan; EULMESEKIAN, Pablo; KAVANAGH, Brian et al.Haematologica (Roma). 2007, Vol 92, Num 2, pp 244-247, issn 0390-6078, 4 p.Article

Association of age, gender, and weight on maintenance dose of intravenous unfractionated heparinVERMA, Siddharth; KATO, Shumei; BLUM, Ronald et al.American journal of hematology. 2010, Vol 85, Num 8, pp 624-626, issn 0361-8609, 3 p.Article

Long-Term Use of Low-Molecular-Weight Heparin in Hemodialysis Patients : A 7-Year ExperienceBERNIEH, B; BOOBES, Y; AL HAKIM, M. R et al.Blood purification. 2009, Vol 27, Num 3, pp 242-245, issn 0253-5068, 4 p.Article

The effect of unfractionated heparin on circulating lymphocyte counts and subsets in humansO'REGAN, Anthony W; SADEH, Jonathan; BERMAN, Jeffrey S et al.Thrombosis research. 2002, Vol 106, Num 1, pp 31-33, issn 0049-3848Article

Monitoring of unfractionated heparin with the activated partial thromboplastin time: determination of therapeutic rangesVAN DEN BESSELAAR, A. M. H. P; STURK, A; REIJNIERSE, G. L. A et al.Thrombosis research. 2002, Vol 107, Num 5, pp 235-240, issn 0049-3848, 6 p.Article

Antifactor Xa Levels versus Activated Partial Thromboplastin Time for Monitoring Unfractionated HeparinVANDIVER, Jeremy W; VONDRACEK, Thomas G.Pharmacotherapy. 2012, Vol 32, Num 6, pp 546-558, issn 0277-0008, 13 p.Article

Heparin - a Key Drug in the Treatment of the Circulatory Degenerative Diseases: Controlling its Action with PolymersSZCZUBIALKA, Krzysztof; KAMINSKI, Kamil; ZASADA, Katarzyna et al.Current pharmaceutical design (Print). 2012, Vol 18, Num 18, pp 2591-2606, issn 1381-6128, 16 p.Article

Unfractionated Heparin for the Treatment of Venous Thromboembolism: Best Practices and Areas of UncertaintyCUKER, Adam.Seminars in thrombosis and hemostasis. 2012, Vol 38, Num 6, pp 593-599, issn 0094-6176, 7 p.Article

Movement of Heparins Across Rat Gastric Mucosa is Dependent on Molecular Weight and pHMOAZED, Bita; HIEBERT, Linda M.Pharmaceutical research. 2009, Vol 26, Num 1, pp 189-195, issn 0724-8741, 7 p.Article

Effects of four commercially available factor Xa proteins on the fluorogenic anti-factor Xa assay when monitoring unfractionated heparinCASTRO-LOPEZ, Vanessa; MURRAY, Brian; HARRIS, Leanne F et al.Blood coagulation & fibrinolysis. 2012, Vol 23, Num 1, pp 98-103, issn 0957-5235, 6 p.Article

Lack of clinically significant pharmacological interactions between ticagrelor and enoxaparin or unfractionated heparin in healthy subjectsTENG, R; BUTLER, K.Journal of clinical pharmacy and therapeutics (Print). 2012, Vol 37, Num 6, pp 704-711, issn 0269-4727, 8 p.Article

Effects of nadroparin, enoxaparin, and unfractionated heparin on endogenous factor Xa and lla formation and on thrombelastometry profilesCVIRN, Gerhard; WAGNER, Thomas; JUERGENS, Guenther et al.Blood coagulation & fibrinolysis. 2009, Vol 20, Num 1, pp 71-77, issn 0957-5235, 7 p.Article

Novel Approaches for Preventing or Limiting Events (NAPLES III) Trial: Randomised Comparison of Bivalirudin Versus Unfractionated Heparin in Patients at High Risk of Bleeding Undergoing Elective Coronary Stenting Throught The Femoral Approach. Rationale and DesignBRIGUORI, Carlo; VISCONTI, Gabriella; FOCACCIO, Amelia et al.Cardiovascular drugs and therapy. 2014, Vol 28, Num 3, pp 273-279, issn 0920-3206, 7 p.Article